BETA INNOV has a total of 42 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2010. It filed its patents most often in EPO (European Patent Office), Canada and China. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and measurement are JENAPHARM GMBH, JENAPHARM GMBH AND CO KG and INTERCEPT PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | Canada | 3 | |
#3 | China | 3 | |
#4 | Hungary | 3 | |
#5 | Serbia | 3 | |
#6 | United States | 3 | |
#7 | WIPO (World Intellectual Property Organization) | 3 | |
#8 | Brazil | 2 | |
#9 | Hong Kong | 2 | |
#10 | Japan | 2 | |
#11 | Russian Federation | 2 | |
#12 | Slovenia | 2 | |
#13 | Argentina | 1 | |
#14 | Australia | 1 | |
#15 | France | 1 | |
#16 | Israel | 1 | |
#17 | India | 1 | |
#18 | Republic of Korea | 1 | |
#19 | Montenegro | 1 | |
#20 | Singapore | 1 | |
#21 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Steroids | |
#4 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Mersel Marcel | 36 |
#2 | Rakotoarivelo Clovis | 21 |
#3 | Petite Didier | 15 |
#4 | Clarion Ludovic | 15 |
#5 | Clovis Rakotoarivelo | 2 |
#6 | Mareel Mersel | 2 |
#7 | Mersel Marsel | 2 |
#8 | Didier Petite | 2 |
#9 | Ludovic Clarion | 2 |
#10 | Marcel Mersel | 2 |
Publication | Filing date | Title |
---|---|---|
EP3593789A1 | Composition containing a 7-beta-hydroxycholesterol derivative and a lipid carrier, and use thereof in the treatment of neoplastic pathologies | |
FR3013048A1 | STEROL DERIVATIVE, PROCESS FOR PREPARING THE SAME, PHARMACEUTICAL COMPOSITION CONTAINING THE SAME, AND USE THEREOF FOR THE TREATMENT OF MULTIMEDIA GLIOBLASTOMA | |
EP2662382A1 | Sterol derivatives, method for preparing same, pharmaceutical compositions containing same and use thereof for the treatment of multiple glioblastomas | |
EP2374470A1 | Therapeutic use of the Beta2m protein |